GME
GameStop Corp.
GME offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SGHC
Super Group (SGHC) Limited
SGHC has the edge over GME overall, supported by stronger modeled upside and lower modeled downside.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
SGHC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Strong |
SGHC's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME has the edge over SGHC in the historical PE scenario, which offers more potential upside but is not a forecast.
SGHC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.6x | $4.10 | -64% |
| Forward | 13x | $11.42 | — |
| Current | 16x | $11.42 | — |
| Fair | 23x | $16.77 | +47% |
| Expensive | 52x | $37.98 | +233% |
Historical ranges are pointers, not guarantees.
SGHC's PE is in its fair range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
SGHC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
SGHC has the edge over GME on the outlook, with more favorable valuation and earnings expectations.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME has the edge over SGHC on earnings, with more consistent year-over-year improvement.
SGHC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.87 | +19% |
| Q2 2026 | $0.73 | +161% |
| Q1 2026 | $0.48 | +66% |
| Q4 2025 | $0.44 | +69% |
| Q3 2025 | $0.46 | +2200% |
| Q2 2025 | $0.28 | +1300% |
| Q1 2025 | $0.29 | +262% |
| Q4 2024 | $0.26 | +$0.28 |
| Q3 2024 | $0.02 | -80% |
SGHC earned $0.73 per share over the past year, up 161% from the year before.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME's operating margin was 20% last quarter, up 13 points from the same quarter a year ago, near the top of its range since 2019.
SGHC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $684M | +0.3% |
| Q1 2026 | $612M | +8% |
| Q4 2025 | $578M | +21% |
| Q3 2025 | $555.7M | +11% |
| Q2 2025 | $681.7M | +48% |
| Q1 2025 | $566.8M | +24% |
| Q4 2024 | $476.5M | +19% |
| Q3 2024 | $499.8M | +26% |
SGHC has the edge over GME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 25% | +7 points |
| Q1 2026 | 20% | +2.7 points |
| Q4 2025 | 17% | -4.2 points |
| Q3 2025 | 25% | +20 points |
| Q2 2025 | 18% | +4.5 points |
| Q1 2025 | 17% | +12 points |
| Q4 2024 | 22% | +23 points |
| Q3 2024 | 5.5% | -2.3 points |
SGHC has the edge over GME on profitability, with a higher operating margin.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the edge over SGHC on cash flow, with more consistent year-over-year improvement.
SGHC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $164M | +$286.3M |
| Q1 2026 | $89M | -63% |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$122.3M | -$122.3M |
| Q1 2025 | $241M | +$241M |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
SGHC generated $253M in free cash flow over the past year, up 113% from the year before.
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has 593M diluted shares, up 8.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
SGHC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +2.8M shares |
| 1 year | +1.9% | +9.3M shares |
| 3 years | +2.2% | +11.2M shares |
| 5 years | +4.6% | +22.4M shares |
SGHC has the edge over GME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
SGHC hasn't bought back shares in the past year.
GME Net Leverage
SGHC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -1.0x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -1.8x | Net Cash |
SGHC has more cash than debt.
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
SGHC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.4 | Neutral |
| Stochastic | 19.2 | Oversold |
SGHC's weekly RSI is 42 (neutral) and its Stochastic is 19 (oversold).
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
SGHC PE vs Consumer Cyclical Sector
| Metric | SGHC | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 13% below |
| PE % | 34 | 49 | 15 pts below |
SGHC has the edge over GME on valuation relative to its sector.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME has the edge over SGHC on trend strength, trading above more of its moving averages.
SGHC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.2 | 1.6% above |
| 20 week MA | $12.8 | 11% below |
| 50 week MA | $12.0 | 4.6% below |
| 100 week MA | $10.8 | 6.1% above |
| 200 week MA | $7.19 | 59% above |
SGHC's trend is mixed: it's above three of its five weekly moving averages, and 59% above its 200-week average.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over SGHC on returns for 2026, with the stronger performance.
SGHC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.73 | $10.2 | +4.6% |
| 2021 | $10.2 | $9.96 | -2.2% |
| 2022 | $9.96 | $2.96 | -70% |
| 2023 | $2.96 | $3.17 | +7.1% |
| 2024 | $3.17 | $6.10 | +92% |
| 2025 | $6.10 | $11.9 | +95% |
| 2026 YTD | $11.9 | $11.4 | -4.2% |
SGHC has finished higher in four of the last six years, two of them by more than 50%. It's down 4.2% so far in 2026.